Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
Frontiers in Pharmacology
|
December 19, 2019
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, et al.
Frontiers in Pharmacology
|
October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US
Chiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.
The Patient
|
June 22, 2019
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA
Rosanne Janssens, Selena Russo, Eline van Overbeeke, et al.
Journal of Market Access & Health Policy
|
March 28, 2024
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
Thomas Desmet, Elaine Julian, Walter Van Dyck, et al.
International Journal of Technology Assessment in Health Care
|
June 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group
Milou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen, et al.
The Lancet. Oncology
|
May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer
Fábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.
Frontiers in Psychology
|
July 10, 2023
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives
Serena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, et al.
BMC Health Services Research
|
July 13, 2021
Patients perspectives on drug shortages in six European hospital settings - a cross sectional study
Darija Kuruc Poje, Domagoj Kifer, Isabelle Huys, et al.
Journal of Market Access & Health Policy
|
June 7, 2023
The role of stakeholder involvement in the evolving EU HTA process:
Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, et al.
Viruses
|
April 6, 2018
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
Christine Rohde, Grégory Resch, Jean-Paul Pirnay, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
Frontiers in Pharmacology
|
December 19, 2019
Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study
Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, et al.
Frontiers in Pharmacology
|
October 18, 2019
Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US
Chiara Whichello, Eline van Overbeeke, Rosanne Janssens, et al.
The Patient
|
June 22, 2019
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA
Rosanne Janssens, Selena Russo, Eline van Overbeeke, et al.
Journal of Market Access & Health Policy
|
March 28, 2024
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
Thomas Desmet, Elaine Julian, Walter Van Dyck, et al.
International Journal of Technology Assessment in Health Care
|
June 16, 2023
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group
Milou Amber Hogervorst, Rick Vreman, Inkatuuli Heikkinen, et al.
The Lancet. Oncology
|
May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer
Fábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.
Frontiers in Psychology
|
July 10, 2023
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives
Serena Oliveri, Lucilla Lanzoni, Jorien Veldwijk, et al.
BMC Health Services Research
|
July 13, 2021
Patients perspectives on drug shortages in six European hospital settings - a cross sectional study
Darija Kuruc Poje, Domagoj Kifer, Isabelle Huys, et al.
Journal of Market Access & Health Policy
|
June 7, 2023
The role of stakeholder involvement in the evolving EU HTA process:
Lauren Van Haesendonck, Jörg Ruof, Thomas Desmet, et al.
Viruses
|
April 6, 2018
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
Christine Rohde, Grégory Resch, Jean-Paul Pirnay, et al.
Page
of 21